Bolt Biotherapeutics (BOLT) Return on Sales (2020 - 2026)
Bolt Biotherapeutics (BOLT) posted Return on Sales of 3.33% for Q1 2026, down 9605.16% sequentially from 0.03% in Q4 2025, and down 323.0% YoY from 1.49% in Q1 2025.
Bolt Biotherapeutics (BOLT) Return on Sales (2020 - 2026) Analysis & Trends
Bolt Biotherapeutics has reported Return on Sales for 7 years, with the latest figure at 3.33% in Q1 2026.
- Quarterly Return on Sales fell 323.0% year-over-year to 3.33% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.15% (up 4.0% YoY) and the FY2025 annual result came in at 0.18%, up 4.0% from the prior year.
- Return on Sales slipped to 3.33% in Q1 2026 per BOLT's latest filing, from 0.03% in the prior quarter.
- Over five years, Return on Sales peaked at 0.03% in Q1 2024 and troughed at 3.33% in Q1 2026.
- A 5-year average of 0.38% and a median of 0.18% in 2025 frame the typical range for Return on Sales.
- The sharpest annual moves came in 2022 and 2026: Return on Sales soared 1490 bps in 2022, then tumbled 323 bps in 2026.
- Over 5 years, Return on Sales stood at 0.15% in 2022, then jumped by 63 bps to 0.06% in 2023, then plunged by 73 bps to 0.1% in 2024, then soared by 65 bps to 0.03% in 2025, then plunged by 9605 bps to 3.33% in 2026.
- According to Business Quant data, Return on Sales over the past three periods registered 3.33%, 0.03%, and 0.18% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 0.00% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.00% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.00% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.00% |
| 10 | Bolt Biotherapeutics | 5.48 Mn | 5.48 Mn | - | -16.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -74.11% |
| Mar 31, 2026 | -3.33% |
| Dec 31, 2025 | -0.03% |
| Sep 30, 2025 | -0.18% |
| Jun 30, 2025 | -0.24% |
| Mar 31, 2025 | -0.10% |
| Dec 31, 2024 | -0.10% |
| Sep 30, 2024 | -0.15% |
| Jun 30, 2024 | -0.17% |
| Mar 31, 2024 | -0.03% |
| Dec 31, 2023 | -0.06% |
| Sep 30, 2023 | -0.19% |
| Jun 30, 2023 | -0.36% |
| Mar 31, 2023 | -0.27% |
| Dec 31, 2022 | -0.15% |
| Sep 30, 2022 | -0.27% |
| Jun 30, 2022 | -0.42% |
| Mar 31, 2022 | -0.34% |
| Dec 31, 2021 | -0.57% |
| Sep 30, 2021 | -0.84% |